Inside the ozempic experience: what users really think
NCT ID NCT07154238
Summary
This is a survey study to learn about the real-world experiences of people using the injectable weight loss medication semaglutide. It will collect online responses from over 2,500 participants in four countries over 14 months. The goal is to understand their satisfaction, weight loss results, and daily life changes while using the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Bad Oeynhausen, 32545, Germany
Conditions
Explore the condition pages connected to this study.